Answers are grounded in this paper and cite their sources.
Systemic immunosuppressive therapy with tacrolimus shows minimal kidney function changes after ocular stem cell transplantation, suggesting its effectiveness.
Systemic immunosuppressive therapy with tacrolimus after ocular surface stem cell transplantation is well tolerated and contributes to high graft survival rates with minimal impact on acute and long-term kidney function.
No takes yet. Share an insight, caveat, or question.
Reinisch et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: